Tricyclic antidepressants and headaches: Systematic review and meta-analysis

BMJ (Online)

Volumn 341, Issue 7778, 2010, Pages 869-

  Jackson, Jeffrey L ^c   Shimeall, William ^a   Sessums, Laura ^a   DeZee, Kent J ^b   Becher, Dorothy ^a   Diemer, Margretta ^a   Berbano, Elizabeth ^a   O'Malley, Patrick G ^b  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c General Medicine Division   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; AMITRIPTYLINOXIDE; BUSPIRONE; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; DIAZEPAM; DIHYDROERGOTAMINE; DOXEPIN; FLUNARIZINE; FLUOXETINE; FLUVOXAMINE; MAPROTILINE; METOPROLOL; MIANSERIN; MIRTAZAPINE; NORTRIPTYLINE; OPIPRAMOL; PLACEBO; PROPRANOLOL; RITANSERIN; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ANXIETY; BLURRED VISION; CLINICAL TRIAL; COGNITIVE THERAPY; CONSTIPATION; DIAPHORESIS; DIZZINESS; DROWSINESS; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG WITHDRAWAL; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; IRRITABILITY; META ANALYSIS; MIGRAINE; NAUSEA; PAIN ASSESSMENT; PRIORITY JOURNAL; PSYCHOGENIC PAIN; PSYCHOPHYSIOLOGY; REVIEW; SIDE EFFECT; SLEEP DISORDER; SYSTEMATIC REVIEW; TENSION HEADACHE; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; VOMITING; WEIGHT GAIN; XEROSTOMIA;

ADULT; ANTIDEPRESSIVE AGENTS, TRICYCLIC; HEADACHE DISORDERS; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEROTONIN UPTAKE INHIBITORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 78049289140     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.c5222     Document Type: Review

References (69)

1. Wang SJ. Epidemiology of migraine and other types of headache in Asia. Curr Neurol Neurosci Rep 2003;3:104-8.
2. Rasmussen BK. Epidemiology of headache. Cephalalgia 2001;21:774-7.
3. Hu XH, Markson LE, Lipton RB, Stewart WF, Berger ML. Burden of migraine in the United States: disability and economic costs. Arch Intern Med 1999;159:813-8.
4. Lance JW, Curan DA. Treatment of chronic tension headache. Lancet 1964;1:1236-9.
5. Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007;68:343-9. (Pubitemid 46184209)
6. Rapaport AM. Recurrent migraine: cost-effective care. Neurology 1994;44(suppl 3):25-8S.
7. Tomkins GE, Jackson JL, O'Malley PG, Balden E, Santoro JE. Treatment of chronic headache with antidepressants: a meta-analysis. Am J Med 2001;111:54-63. (Pubitemid 32635262)
8. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders. 2nd ed. Cephalalgia 2004;24(suppl 1):1-169S.
9. Ad Hoc Committee on the Classification of Headache of the National Institute of Neurological Diseases and Blindness. Classification of headache. JAMA 1962;179:717-8.
10. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8(suppl 7):1-96S.
11. Follmann D, Elliott P, Suh I, Cutler J. Variance imputation for overviews of clinical trials with continuous response. J Clin Epidemiol 1992;45:769-73.
12. Alderson P, Green S, Higgins JPT. Assessment of study quality. In: Alderson P, Green S, Higgins JPT, eds. Cochrane reviewers' handbook 4.2.2. Wiley, 2004.
13. Kazis LE, Anderson JJ, Meenan RF. Effect sizes for interpreting changes in health status. Med Care 1989;27(suppl 3):178-89S.
14. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
15. Galbraith RF. A note on graphical presentation of estimated odds ratios from several clinical trials. Stat Med 1988;7:889-94.
16. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
17. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Comparison of two methods to detect publication bias in meta-analysis. JAMA 2006;295:676-80. (Pubitemid 43209069)
18. Egger M, Davey Smith G, Schneider M, Minder C. Bias in metaanalysis detected by a simple, graphical test.BMJ 1997;315:629-34.
19. Gleser LJ, Olkin I. Models for estimating the number of unpublished studies. Stat Med 1996;15:2493-507. (Pubitemid 26413809)
20. Rosenthal R. The file drawer problem and tolerance for null results. Psychol Bull 1979;86:638-41.
21. Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000;56:55-463.
22. Sharp S. Meta-analysis regression. Stata Tech Bull 1998;42:16-22.
23. Amelin AV, Skoromets AA, Korenko LA, Tumelevich BC, Gonchar MA. [A comparative efficiency of amitriptyline, fluoxetine and maprotiline in prevention of migraine in attack-free period.] Zhurnal Nevropatoliogii I Psikhiatrii Imeni S S Korsakova 2000;100:20-3.
24. Bank J. A comparative study of amitriptyline and fluvoxamine in migraine prophylaxis. Headache 1994;34:476-8.
25. Bendtsen L, Jensen R, Olesen J. A non-selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache. J Neurol Neurosurg Psychiatr 1996;61:285-90. (Pubitemid 26293724)
26. Boline PD, Kassak K, Bronfort G, Nelson C, Anderson AV. Spinal manipulation vs amitriptyline for the treatment of chronic tension-type headaches: a randomized clinical trial. J Manipulative Physiol Ther 1995;18:148-54.
27. Bonuso S, Di Stasio E, Barone P, Steardo L. Timed-release dihydroergotamine in the prophylaxis of mixed headache. A study versus amitriptyline. Cephalalgia 1983;3(suppl 1):175-8.
28. Boz C, Altunayoglu V, Velioglu S, Ozmenoglu M. Sertraline versus amitriptyline in the prophylactic therapy of non-depressed chronic tension-type headache patients. J Headache Pain 2003;4:72-8. (Pubitemid 37062820)
29. Bulut S, Berilgen MS, Baran A, Tekatas A, Atmaca M, Mungen B. Venlafaxine versus amitriptyline in the prophylactic treatment of migraine: randomized, double-blind, crossover study. Clin Neurol Neurosurg 2004;107:44-8. (Pubitemid 39556678)
30. Canepari C, Riva M, Erminio F. [Effectiveness of flunarizine in chronic headache. Double-blind study of placebo and amitriptyline.] La Clinica Terapeutica 1985;115:463-8.
31. Couch JR, Ziegler DK, Hassanein RS. Evaluation of amitriptyline in migraine prophylaxis. Trans Am Neurol Assoc 1974;99:94-9.
32. Couch JR, Hassanein RS. Migraine and depression: effect of amitriptyline prophylaxis. Trans Am Neurol Assoc 1976;101:234-7.
33. Diamond S, Baltes BJ. Chronic tension headache - treated with amitriptyline - a double-blind study. Headache 1971;11:110-6.
34. Dodick DW, Freitag F, Banks J, Saper J, Xiang J, Rupnow M, et al. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs. Clin Ther 2009;31:542-59.
35. Gobel H, Hamouz V, Hansen C, Heininger K, Hirsch S, Lindner V, et al. Chronic tension-type headache: amitriptyline reduces clinical headache-duration and experimental pain sensitivity but does not alter pericranial muscle activity readings. Pain 1994;59:241-9.
36. Gomersall JD, Stuart A. Amitriptyline in migraine prophylaxis. Changes in pattern of attacks during a controlled clinical trial. J Neurol Neurosurg Psychiatr 1973;36:684-90.
37. Holroyd KA, Nash JM, Pingel JD, Cordingley GE, Jerome A. A comparison of pharmacological (amitriptyline HCL) and nonpharmacological (cognitive- behavioral) therapies for chronic tension headaches. J Consult Clin Psychol 1991;59:387-93.
38. Holroyd KA, O'Donnell FJ, Stensland M, Lipchik GL, Cordingley GE, Carlson BW. Management of chronic tension-type headache with tricyclic antidepressant medication, stress management therapy, and their combination: a randomized controlled trial. J Am Med Assoc 2001;285:2208-15.
39. Indaco A, Carrieri PB. Amitriptyline in the treatment of headache in patients with Parkinson's disease: a double-blind placebo-controlled study. Neurology 1988;38:1720-2. (Pubitemid 18265035)
40. Jacobs H. A trial of opipramol in the treatment of migraine. J Neurol Neurosurg Psychiatr 1972;35:500-4.
41. Keskinbora K, Aydinli I. A double-blind randomized controlled trial of topiramate and amitriptyline either alone or in combination for the prevention of migraine. Clin Neurol Neurosurg 2008;110:979-84.
42. Langemark M, Loldrup D, Bech P, Olesen J. Clomipramine and mianserin in the treatment of chronic tension headache. A double-blind, controlled study. Headache 1990;30:118-21.
43. Langohr HD, Gerber WD, Koletzki E, Mayer K, Schroth G. Clomipramine and metoprolol in migraine prophylaxis - a double-blind crossover study. Headache 1985;25:107-13. (Pubitemid 15108318)
44. Loldrup D, Langemark M, Hansen HJ, Olesen J, Bech P. Clomipramine and mianserin in chronic idiopathic pain syndrome. A placebo controlled study. Psychopharmacology 1989;99:1-7.
45. Martin-Araguz A, Bustamante-Martinez C, Pedro-Pijoan JM. [Treatment of chronic tension type headache with mirtazapine and amitriptyline]. Revista de Neurologia 2003;37:101-5.
46. Mathew NT. Prophylaxis of migraine and mixed headache. A randomized controlled study. Headache 1981;21:105-9.
47. Mitsikostas DD, Gatzonis S, Thomas A, Ilias A. Buspirone vs amitriptyline in the treatment of chronic tension-type headache. Acta Neurol Scand 1997;96:247-51. (Pubitemid 27402493)
48. Morland TJ, Storli OV, Mogstad TE. Doxepin in the prophylactic treatment of mixed "vascular" and tension headache. Headache 1979;19:382-3.
49. Nappi G, Sandrini G, Granella F, Ruiz L, Cerutti G, Facchinetti F, et al. A new 5-HT2 antagonist (ritanserin) in the treatment of chronic headache with depression. A double-blind study vs amitriptyline. Headache 1990;30:439-44.
50. Nelson CF, Bronfort G, Evans R, Boline P, Goldsmith C, Anderson AV. The efficacy of spinal manipulation, amitriptyline and the combination of both therapies for the prophylaxis of migraine headache. J Manipulative Physiol Ther 1998;21:511-9. (Pubitemid 28491482)
51. Noone JF. Clomipramine in the prevention of migraine. J Int Med Res 1980;8(suppl 3):49-52S.
52. Okasha A, Ghaleb HA, Sadek A. A double blind trial for the clinical management of psychogenic headache. Br J Psychiatry 1973;122:181-3.
53. Pfaffenrath V, Diener HC, Isler H, Meyer C, Scholz E, Taneri Z, et al. Efficacy and tolerability of amitriptylinoxide in the treatment of chronic tension-type headache: a multi-centre controlled study. Cephalalgia 1994;14:149-55.
54. Rampello L, Alvano A, Chiechio S, Malaguarnera M, Raffaele R, Vecchio I, et al. Evaluation of the prophylactic efficacy of amitriptyline and citalopram, alone or in combination, in patients with comorbidity of depression, migraine, and tension-type headache. Neuropsychobiology 2004;50:322-8.
55. Tarasova SV, Amelin AV, Skoromets AA. Fluvoxamine, amitriptyline and transcranial electrostimulation of the brain in the treatment of chronic daily headache. Zhurnal Nevropatoliogii I Psikhiatrii Imeni S S Korsakova 2009;108:43-6.
56. Vernon H, Jansz G, Goldsmith CH, McDermaid C. A randomized, placebo-controlled clinical trial of chiropractic and medical prophylactic treatment of adults with tension-type headache: results from a stopped trial. J Manipulative Physiol Ther 2009;32:344-51.
57. Walker Z, Walker RWH, Robertson MM, Stansfeld S. Antidepressant treatment of chronic tension-type headache: a comparison between fluoxetine and desipramine. Headache 1998;38:523-8.
58. Ziegler DK, Hurwitz A, Hassanein RS, Kodanaz HA, Preskorn SH, Mason J. Migraine prophylaxis. A comparison of propranolol and amitriptyline. Arch Neurol 1987;44:486-9.
59. Okasha A, Ghaleb HA, Sadek A. A double blind trial for the clinical management of psychogenic headache. Br J Psychiatry 1973;122:181-3.
60. Moja PL, Cusi C, Sterzi RR, Canepari C. Selective serotonin re-uptake inhibitors (SSRIs) for preventing migraine and tension-type headaches. Cochrane Database Syst Rev 2005;3:CD002919.
61. Jackson JL, O'Malley PG, Kroenke K. Clinical predictors of mental disorders among medical outpatients. Validation of the "S4" model. Psychosomatics 1988;39:431-6.
62. Kroenke K, Spitzer RL, Williams JB, Linzer M, Hahn SR, deGruy FV, et al. Physical symptoms in primary care. Predictors of psychiatric disorders and functional impairment. Arch Fam Med 1994;3:774-9.
63. Kroenke K, Jackson JL, Chamberlin J. Depressive and anxiety disorders in patients presenting with physical complaints: clinical predictors and outcome. Am J Med 1997;103:339-47. (Pubitemid 27506238)
64. Garvey MJ, Schaffer CB, Tuason VB. Relationship of headaches to depression. Br J Psychiatry 1983;143:544-7.
65. Hendler N. Depression caused by chronic pain. J Clin Psychiatry 1984;45:30-8.
66. Botney M, Fields JL. Amitriptyline potentiates morphine analgesia by a direct action on the central nervous system. Ann Neurol 1983;13:160-4. (Pubitemid 13188210)
67. Eberhard G, Von Knorring L, Nilsson HL, SundequistU, Wahlander L. Predictors for the outcome of treatment with antidepressants in patients with idiopathic pain syndromes. Nord Psykiatr Tidsskr 1989;43:114-20.
68. Anderson ED. An ascending serotoninergic pain modulation pathway from the dorsal raphe nucleus to the parafascicularis nucleus of the thalamus. Brain Res 1983;269:67-77.
69. Terrin N, Schmid CH, Lau J, Olkin I. Adjusting for publication bias in the presence of heterogeneity. Stat Med 2003;22:2113-26.